GlassScriptPhysician profile
Joshua Patrick Leitner
NPI 1992729388
$8,217.11
in general payments reported to CMS, 2019-2025
19 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $42.77 · 2021: $146 · 2022: $510 · 2023: $2,354 · 2024: $2,347 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,746 · Travel and Lodging: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,745.74 |
| Travel and Lodging | $2,404.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,714.36 | 2019-2025 | Amplatzer Amulet, Portico, Coroflow |
| Edwards Lifesciences Corporation | $2,454.86 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,815.72 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Rotapro |
| Medtronic, INC. | $278.24 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Abiomed | $155.10 | 2025 | |
| Pfizer INC. | $131.87 | 2023-2025 | |
| Medtronic Vascular, INC. | $127.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Philips North America LLC | $105.41 | 2025 | Coronary Other |
| Alnylam Pharmaceuticals INC. | $89.19 | 2024 | Amvuttra |
| Cardiovascular Systems INC. | $37.51 | 2023 | Diamondback Coronary |
| Cardiva Medical, INC. | $34.98 | 2023-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Biosense Webster, INC. | $32.65 | 2021 | |
| Merck Sharp & Dohme LLC | $23.55 | 2025 | Winrevair |
| Atricure, INC. | $20.12 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $20.06 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Angle, Sublime Microcatheter, 014, 65cm, Straight |
| Davol INC. | $17.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.22 | 2019 | |
| W. L. Gore & Associates, INC. | $16.24 | 2025 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Leitner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.